Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30
Published July 8, 2026 · Recall initiated: June 1, 2026
Summary
FDA records drug Class III recall D-0654-2026, published July 8, 2026 and initiated June 1, 2026. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Ongoing; Reported quantity: 9,048 bottles; Lot: Lot, expiry: Lot DNG0283A, exp 03/31/2027; Lots DNF0922A and DNF0923B, exp 10/31/2026. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Distributor
- U.S. Nationwide
- Lot
- Lot, expiry: Lot DNG0283A, exp 03/31/2027; Lots DNF0922A and DNF0923B, exp 10/31/2026
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATretinoin Cream UPS, 0.05%, 20g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6TOctober 14, 2026
- FDATretinoin Cream USP, 0.05%, 45g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, CanadaOctober 14, 2026
- FDATretinoin Cream USP, 0.05%, 45 g tube, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by:October 14, 2026
- FDACarbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro PharmaceuticalAugust 26, 2026
- FDAIMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured byJuly 8, 2026
- FDAprednisoLONE Acetate Ophthalmic Suspension, USP, 1%, Rx only, Sterile, a) 5 mL (NDC 70748-332-02); b) 10 mLJuly 8, 2026
Questions about this recall
Was Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30 recalled?
Yes. FDA published recall D-0654-2026 on July 8, 2026. Reported hazard: Failed Impurities/Degradation Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter